Nuclear orphan receptor Nor-1 contributes to depressive behavior in the Wistar-Kyoto rat model of depression

Brain Research

Volumn 1362, Issue , 2010, Pages 32-39

  Schaffer, Daniel J ^a   Tunc Ozcan, Elif ^a   Shukla, Pradeep K ^a   Volenec, Andreja ^a   Redei, Eva E ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Desipramine; Glucocorticoid receptor; Nuclear orphan receptor 1; Short hairpin RNA; Wistar Kyoto rat depression

Indexed keywords

CELL NUCLEUS RECEPTOR; DESIPRAMINE; GLUCOCORTICOID RECEPTOR; MESSENGER RNA; NUCLEAR ORPHAN RECEPTOR 1; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DEPRESSION; DRUG MECHANISM; ELECTRIC SHOCK; FORCED SWIMMING TEST; GENE TARGETING; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; WISTAR KYOTO RAT;

ANIMALS; BRAIN; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NERVE TISSUE PROTEINS; NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 1; RATS; RATS, INBRED WKY; RATS, SPRAGUE-DAWLEY; RECEPTORS, GLUCOCORTICOID; RECEPTORS, STEROID; RECEPTORS, THYROID HORMONE;

ANIMALIA; RATTUS;

EID: 78149357979     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2010.09.041     Document Type: Article

References (63)

1. C. Anacker, P.A. Zunszain, L.A. Carvalho, and C.M. Pariante The glucocorticoid receptor: pivot of depression and of antidepressant treatment? Psychoneuroendocrinology 2010 [Epub ahead of print]
2. S. Bandoh, T. Tsukada, K. Maruyama, N. Ohkura, and K. Yamaguchi Gene expression of NOR-1, a neuron-derived orphan receptor, is inducible in neuronal and other cell lineages in culture Mol. Cell. Endocrinol. 115 1995 227 230
3. J.K. Belanoff, A.J. Rothschild, F. Cassidy, C. DeBattista, E.E. Baulieu, C. Schold, and A.F. Schatzberg An open label trial of C-1073 (mifepristone) for psychotic major depression Biol. Psychiatry 52 2002 386 392
4. L. Bjartmar, I.M. Johansson, J. Marcusson, S.B. Ross, J.R. Seckl, and T. Olsson Selective effects on NGFI-A, MR, GR and NGFI-B hippocampal mRNA expression after chronic treatment with different subclasses of antidepressants in the rat Psychopharmacology (Berl) 151 2000 7 12
5. M.E. Bonnet, P. Erbacher, and A.L. Bolcato-Bellemin Systemic delivery of DNA or siRNA mediated by linear polyethylenimine (L-PEI) does not induce an inflammatory response Pharm. Res. 25 2008 2972 2982
6. M.P. Boyle, J.A. Brewer, M. Funatsu, D.F. Wozniak, J.Z. Tsien, Y. Izumi, and L.J. Muglia Acquired deficit of forebrain glucocorticoid receptor produces depression-like changes in adrenal axis regulation and behavior Proc. Natl Acad. Sci. USA 102 2005 473 478
7. L.S. Brady, H.J. Whitfield Jr., R.J. Fox, P.W. Gold, and M. Herkenham Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. Therapeutic implications J Clin Invest. 87 1991 831 837
8. J.D. Bremner, M. Narayan, E.R. Anderson, L.H. Staib, H.L. Miller, and D.S. Charney Hippocampal volume reduction in major depression Am. J. Psychiatry 157 2000 115 118
9. S. Brunner, E. Furtbauer, T. Sauer, M. Kursa, and E. Wagner Overcoming the nuclear barrier: cell cycle independent nonviral gene transfer with linear polyethylenimine or electroporation Mol. Ther. 5 2002 80 86
10. B. Budziszewska, and W. Lason Pharmacological modulation of glucocorticoid and mineralocorticoid receptors in the rat central nervous system Pol. J. Pharmacol. 46 1994 97 102
11. G.V. Carr, D.A. Bangasser, T. Bethea, M. Young, R.J. Valentino, and I. Lucki Antidepressant-like effects of kappa-opioid receptor antagonists in Wistar Kyoto rats Neuropsychopharmacology 35 2010 752 763
12. H.E. Covington III, I. Maze, Q.C. LaPlant, V.F. Vialou, Y.N. Ohnishi, O. Berton, D.M. Fass, W. Renthal, A.J. Rush III, E.Y. Wu, S. Ghose, V. Krishnan, S.J. Russo, C. Tamminga, S.J. Haggarty, and E.J. Nestler Antidepressant actions of histone deacetylase inhibitors J. Neurosci. 29 2009 11451 11460
13. C. DeBattista, and J. Belanoff The use of mifepristone in the treatment of neuropsychiatric disorders Trends Endocrinol. Metab. 17 2006 117 121
14. M.J. Detke, M. Rickels, and I. Lucki Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants Psychopharmacology 121 1995 66 72
15. W.C. Drevets Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders Curr. Opin. Neurobiol. 11 2001 240 249
16. W.C. Drevets, J.L. Price, M.E. Bardgett, T. Reich, R.D. Todd, and M.E. Raichle Glucose metabolism in the amygdala in depression: relationship to diagnostic subtype and plasma cortisol levels Pharmacol. Biochem. Behav. 71 2002 431 447
17. D.M. Fass, J.E. Butler, and R.H. Goodman Deacetylase activity is required for cAMP activation of a subset of CREB target genes J. Biol. Chem. 278 2003 43014 43019
18. V. Giguere Orphan nuclear receptors: from gene to function Endocr. Rev. 20 1999 689 725
19. W.T. Godbey, K.K. Wu, and A.G. Mikos Tracking the intracellular path of poly(ethylenimine)/DNA complexes for gene delivery Proc. Natl Acad. Sci. USA 96 1999 5177 5181
20. D. Goula, J.S. Remy, P. Erbacher, M. Wasowicz, G. Levi, B. Abdallah, and B.A. Demeneix Size, diffusibility and transfection performance of linear PEI/DNA complexes in the mouse central nervous system Gene Ther. 5 1998 712 717
21. Z. Hassani, J.C. Francois, G. Alfama, G.M. Dubois, M. Paris, C. Giovannangeli, and B.A. Demeneix A hybrid CMV-H1 construct improves efficiency of PEI-delivered shRNA in the mouse brain Nucleic Acids Res. 35 2007 e65
22. R.S. Hastings, R.V. Parsey, M.A. Oquendo, V. Arango, and J.J. Mann Volumetric analysis of the prefrontal cortex, amygdala, and hippocampus in major depression Neuropsychopharmacology 29 2004 952 959
23. W. Heydendael, and L. Jacobson Differential effects of imipramine and phenelzine on corticosteroid receptor gene expression in mouse brain: potential relevance to antidepressant response Brain Res. 1238 2008 93 107
24. F. Holsboer The corticosteroid receptor hypothesis of depression Neuropsychopharmacology 23 2000 477 501
25. H. Jahn, M. Schick, F. Kiefer, M. Kellner, A. Yassouridis, and K. Wiedemann Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial Arch. Gen. Psychiatry 61 2004 1235 1244
26. I.M. Johansson, L. Bjartmar, J. Marcusson, S.B. Ross, J.R. Seckl, and T. Olsson Chronic amitriptyline treatment induces hippocampal NGFI-A, glucocorticoid receptor and mineralocorticoid receptor mRNA expression in rats Brain Res. Mol. Brain Res. 62 1998 92 95
27. O. Johren, A. Dendorfer, P. Dominiak, and W. Raasch Gene expression of mineralocorticoid and glucocorticoid receptors in the limbic system is related to type-2 like diabetes in leptin-resistant rats Brain Res. 1184 2007 160 167
28. I. Kitayama, A.M. Janson, A. Cintra, K. Fuxe, L.F. Agnati, S.O. Ogren, A. Harfstrand, P. Eneroth, and J.A. Gustafsson Effects of chronic imipramine treatment on glucocorticoid receptor immunoreactivity in various regions of the rat brain. Evidence for selective increases of glucocorticoid receptor immunoreactivity in the locus coeruleus and in 5-hydroxytryptamine nerve cell groups of the rostral ventromedial medulla J. Neural Transm. 73 1988 191 203
29. A. Lopez, A. Boccellari, and K. Hall Posttraumatic stress disorder in a Central American refugee Hosp. Community Psychiatry 39 1988 1309 1311
30. C. Lopez-Rubalcava, and I. Lucki Strain differences in the behavioral effects of antidepressant drugs in the rat forced swimming test Neuropsychopharmacology 22 2000 191 199
31. J. Maheux, I. Ethier, C. Rouillard, and D. Levesque Induction patterns of transcription factors of the nur family (nurr1, nur77, and nor-1) by typical and atypical antipsychotics in the mouse brain: implication for their mechanism of action J. Pharmacol. Exp. Ther. 313 2005 460 473
32. G.N. Neigh, and C.B. Nemeroff Reduced glucocorticoid receptors: consequence or cause of depression? Trends Endocrinol. Metab. 17 2006 124 125
33. W.P. Pare Investigatory behavior of a novel conspecific by Wistar Kyoto, Wistar and Sprague-Dawley rats Brain Res. Bull. 53 2000 759 765
34. W.P. Pare, and E. Redei Depressive behavior and stress ulcer in Wistar Kyoto rats J. Physiol. Paris 87 1993 229 238
35. C.M. Pariante The glucocorticoid receptor: part of the solution or part of the problem? J. Psychopharmacol. 20 2006 79 84
36. C.M. Pariante, and A.H. Miller Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment Biol. Psychiatry 49 2001 391 404
37. C.M. Pariante, A. Makoff, S. Lovestone, S. Feroli, A. Heyden, A.H. Miller, and R.W. Kerwin Antidepressants enhance glucocorticoid receptor function in vitro by modulating the membrane steroid transporters Br. J. Pharmacol. 134 2001 1335 1343
38. C.M. Pariante, S.A. Thomas, S. Lovestone, A. Makoff, and R.W. Kerwin Do antidepressants regulate how cortisol affects the brain? Psychoneuroendocrinology 29 2004 423 447
39. K.A. Pearson, A. Stephen, S.G. Beck, and R.J. Valentino Identifying genes in monoamine nuclei that may determine stress vulnerability and depressive behavior in Wistar-Kyoto rats Neuropsychopharmacology 31 2006 2449 2461
40. L. Pei, H. Waki, B. Vaitheesvaran, D.C. Wilpitz, I.J. Kurland, and P. Tontonoz NR4A orphan nuclear receptors are transcriptional regulators of hepatic glucose metabolism Nat. Med. 12 2006 1048 1055
41. A. Peiffer, S. Veilleux, and N. Barden Antidepressant and other centrally acting drugs regulate glucocorticoid receptor messenger RNA levels in rat brain Psychoneuroendocrinology 16 1991 505 515
42. M.C. Pepin, F. Pothier, and N. Barden Impaired type II glucocorticoid-receptor function in mice bearing antisense RNA transgene Nature 355 1992 725 728
43. M.G. Proescholdt, B. Hutto, L.S. Brady, and M. Herkenham Studies of cerebrospinal fluid flow and penetration into brain following lateral ventricle and cisterna magna injections of the tracer [14C]inulin in rat Neuroscience 95 2000 577 592
44. E. Przegalinski, and B. Budziszewska The effect of long-term treatment with antidepressant drugs on the hippocampal mineralocorticoid and glucocorticoid receptors in rats Neurosci. Lett. 161 1993 215 218
45. E. Redei, W.P. Pare, F. Aird, and J. Kluczynski Strain differences in hypothalamic-pituitary-adrenal activity and stress ulcer Am. J. Physiol. 266 1994 R353 R360
46. E.E. Redei, N. Ahmadiyeh, A. Baum, D. Sasso, J. Slone, L.C. Solberg, C. Will, and A. Volenec Novel animal models of affective disorders G.J. Tucker, W. McKinney, Seminars in Clinical Neuropsychiatry vol. 6 2001 W.B. Saunders Company Philadelphia
47. J.M. Reul, I. Stec, M. Soder, and F. Holsboer Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic-pituitary-adrenocortical system Endocrinology 133 1993 312 320
48. J.M. Reul, M.S. Labeur, D.E. Grigoriadis, E.B. De Souza, and F. Holsboer Hypothalamic-pituitary-adrenocortical axis changes in the rat after long-term treatment with the reversible monoamine oxidase-A inhibitor moclobemide Neuroendocrinology 60 1994 509 519
49. J.R. Seckl, and G. Fink Antidepressants increase glucocorticoid and mineralocorticoid receptor mRNA expression in rat hippocampus in vivo Neuroendocrinology 55 1992 621 626
50. Y.I. Sheline, K.J. Black, D.Y. Lin, G.E. Christensen, M.H. Gado, B.S. Brunsden, and M.W. Vannier Stereological MRI volumetry of the frontal lobe Psychiatry Res. 67 1996 203 214
51. Y.I. Sheline, M.H. Gado, and J.L. Price Amygdala core nuclei volumes are decreased in recurrent major depression NeuroReport 9 1998 2023 2028
52. Y.I. Sheline, M. Sanghavi, M.A. Mintun, and M.H. Gado Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression J. Neurosci. 19 1999 5034 5043
53. G.J. Siegle, S.R. Steinhauer, M.E. Thase, V.A. Stenger, and C.S. Carter Can't shake that feeling: event-related fMRI assessment of sustained amygdala activity in response to emotional information in depressed individuals Biol. Psychiatry 51 2002 693 707
54. G.J. Siegle, W. Thompson, C.S. Carter, S.R. Steinhauer, and M.E. Thase Increased amygdala and decreased dorsolateral prefrontal BOLD responses in unipolar depression: related and independent features Biol. Psychiatry 61 2007 198 209
55. L.C. Solberg, N. Ahmadiyeh, A.E. Baum, M.H. Vitaterna, J.S. Takahashi, F.W. Turek, and E.E. Redei Depressive-like behavior and stress reactivity are independent traits in a Wistar Kyoto x Fisher 344 cross Mol. Psychiatry 8 2003 423 433
56. L.C. Solberg, A.E. Baum, N. Ahmadiyeh, K. Shimomura, R. Li, F.W. Turek, G.A. Churchill, J.S. Takahashi, and E.E. Redei Sex- and lineage-specific inheritance of depression-like behavior in the rat Mamm. Genome 15 2004 648 662
57. W. Sun, K.W. Park, J. Choe, I.J. Rhyu, I.H. Kim, S.K. Park, B. Choi, S.H. Choi, S.H. Park, and H. Kim Identification of novel electroconvulsive shock-induced and activity-dependent genes in the rat brain Biochem. Biophys. Res. Commun. 327 2005 848 856
58. W. Sun, S.H. Choi, S.K. Park, S.J. Kim, M.R. Noh, E.H. Kim, H.J. Kim, and H. Kim Identification and characterization of novel activity-dependent transcription factors in rat cortical neurons J. Neurochem. 100 2007 269 278
59. D.R. Thakker, F. Natt, D. Husken, R. Maier, M. Muller, H. van der Putten, D. Hoyer, and J.F. Cryan Neurochemical and behavioral consequences of widespread gene knockdown in the adult mouse brain by using nonviral RNA interference Proc. Natl Acad. Sci. USA 101 2004 17270 17275
60. P. van Eijndhoven, G. van Wingen, K. van Oijen, M. Rijpkema, B. Goraj, R. Jan Verkes, R. Oude Voshaar, G. Fernandez, J. Buitelaar, and I. Tendolkar Amygdala volume marks the acute state in the early course of depression Biol. Psychiatry 65 2009 812 818
61. J.S. Wilcoxon, and E.E. Redei Prenatal programming of adult thyroid function by alcohol and thyroid hormones Am. J. Physiol. Endocrinol. Metab. 287 2004 E318 E326
62. J.S. Wilcoxon, A.G. Kuo, J.F. Disterhoft, and E.E. Redei Behavioral deficits associated with fetal alcohol exposure are reversed by prenatal thyroid hormone treatment: a role for maternal thyroid hormone deficiency in FAE Mol. Psychiatry 10 2005 961 971
63. K. Wu, C.A. Meyers, J.A. Bennett, M.A. King, E.M. Meyer, and J.A. Hughes Polyethylenimine-mediated NGF gene delivery protects transected septal cholinergic neurons Brain Res. 1008 2004 284 287